STOCK TITAN

Athenex (ATNX) Stock Price, News & Analysis

ATNX
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
96 252 sessions, May 24, 2022 to May 24, 2023
Largest daily move
-60.7% close of May 15, 2023
1-year change
-98% closing prices, May 24, 2022 to May 24, 2023
1-month change
-83.8% closing prices, April 24, 2023 to May 24, 2023

Company Description

Athenex (Nasdaq: ATNX) is classified in the drug manufacturers—specialty & generic industry within the Healthcare sector.

ATNX declined 98.0% in the 12 months to May 24, 2023. The last closing price was $0.2031.

This page collects what Stock Titan holds for ATNX, including price data and latest news.

Stock Performance

$0.2031
No recent trading
Last close: May 24, 2023
-98%
1 year to May 24, 2023

Athenex (ATNX) closed at $0.2031 on May 24, 2023. In the 12 months to May 24, 2023, the price lost 98.0%.

See what a $1,000 investment in ATNX would be worth today

Average down calculator for ATNX

ATNX Metrics & Rankings

Price returns through May 24, 2023. Month and year figures include the first trading day. Ranking links may use different dates.

SEC Filings

No SEC filings available for ATNX.

ATNX Company Profile & Sector Positioning

Athenex (ATNX) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector.

Investors comparing ATNX often look at related companies in the same sector, including Takeda Pharmaceutical Company Limited (TAK), Teva Pharmaceutical Industries Limited (TEVA), Haleon plc (HLN), Zoetis Inc. (ZTS), and United Therapeutics Corp (UTHR). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ATNX's relative position within its industry.

Frequently Asked Questions

Athenex (ATNX) has no recent trading. Its last close was $0.2031 on May 24, 2023.